echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Applications of N-DESMETHYL IMATINIB

    The Applications of N-DESMETHYL IMATINIB

    • Last Update: 2023-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    N-Desmethyl Imatinib: An Essential Compound in Chemical Industry


    N-desmethyl imatinib is a derivative of the original cancer drug imatinib, which is marketed under the brand name Glivec.
    N-desmethyl imatinib is an essential compound in the chemical industry and has various applications in the production of medicines, agrochemicals, and other chemical products.


    One of the most significant applications of N-desmethyl imatinib is in the production of anti-cancer drugs.
    It is a key precursor in the synthesis of a class of drugs known as tyrosine kinase inhibitors (TKIs), which are used to treat various types of cancer.
    N-desmethyl imatinib is used as a starting material in the synthesis of TKIs that target specific tyrosine kinases, such as the Bcr-Abl kinase, which is involved in the development of chronic myeloid leukemia.


    In addition to its use in the production of anti-cancer drugs, N-desmethyl imatinib is also used in the production of agrochemicals.
    It is a precursor in the synthesis of triazole herbicides, which are used to control weeds in crops.
    The triazole herbicides synthesized using N-desmethyl imatinib are effective against a wide range of weed species and have low toxicity to non-target organisms, making them an environmentally friendly option for farmers.


    Another application of N-desmethyl imatinib is in the production of chemical intermediates.
    It is used as a starting material in the synthesis of other chemical compounds that are used in a variety of applications, such as in the production of plastics, dyes, and pharmaceuticals.


    The synthesis of N-desmethyl imatinib involves several steps, including the reduction of imatinib to N-desmethyl imatinib and the subsequent conversion of the latter to the desired product.
    The synthesis of N-desmethyl imatinib can be accomplished using various reduction methods, such as hydrogenation and hydrazine reduction.
    The choice of reduction method depends on the specific requirements of the application and the availability of the necessary equipment and reagents.


    N-desmethyl imatinib is also used in the synthesis of other compounds, such as the anti-malarial drug primaquine and the sedative drug methohexital.
    The use of N-desmethyl imatinib in the synthesis of these compounds highlights its versatility as a starting material in chemical synthesis.


    In conclusion, N-desmethyl imatinib is an essential compound in the chemical industry with various applications in the production of medicines, agrochemicals, and other chemical products.
    Its use in the synthesis of tyrosine kinase inhibitors, triazole herbicides, and other chemical intermediates highlights its versatility and importance in the chemical industry.
    The synthesis of N-desmethyl imatinib involves several steps, and the choice of reduction method depends on the specific requirements of the application.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.